CONTRASTING FIBRINOLYTIC RESPONSES IN TYPE-1 (INSULIN-DEPENDENT) AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES

被引：46

作者：

WALMSLEY, D ^{[1
]}

HAMPTON, KK ^{[1
]}

GRANT, PJ ^{[1
]}

机构：

[1] UNIV LEEDS,GEN INFIRM,DEPT MED,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND

来源：

DIABETIC MEDICINE | 1991年 / 8卷 / 10期

关键词：

DIABETES-MELLITUS; COMPLICATIONS; FIBRINOLYSIS;

D O I：

10.1111/j.1464-5491.1991.tb01536.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

To study fibrinolysis in relation to microvascular diabetic complications, 20 control subjects were compared with 50 Type 1 (insulin-dependent) diabetic patients of similar age, 20 with no complications, 17 with laser-treated retinopathy, and 13 with neuropathy and retinopathy. None were smokers, hypertensive or had macrovascular disease. Pre- and post-venous occlusion blood samples for tests of fibrinolysis were taken. Median (interquartile range) basal tissue plasminogen activator (t-PA) activity was lower in control subjects (100 (< 100-100) IU l-1) than diabetic patients (uncomplicated 145 (100-280) IU l-1, p = 0.015; retinopathy 180 (100-228) IU l-1, p = 0.037; neuropathy 210 (125-310) IU l-1, p = 0.004, respectively). Basal t-PA inhibition (PAI-1 activity) was higher in control subjects (5.9 (4.5-9.5) kIU l-1) than diabetic patients (uncomplicated 4.0 (3.3-5.0) kIU l-1, p = 0.001; retinopathy 4.5 (3.1-6.3) kIU l-1, p = 0.058; neuropathy 4.0 (3.0-5.4) kIU l-1, p = 0.015, respectively). Post-venous occlusion t-PA antigen was higher in control subjects (10.2 (7.3-15.1) mu-g l-1) than neuropathic patients (5.5 (4.9-7.3) mu-g l-1, p = 0.004). Other tests showed a consistent, but non-significant, trend towards increased basal fibrinolysis in the Type 1 diabetic patients. The results indicate that Type 1 diabetic patients have enhanced basal fibrinolysis. The diminished response to venous occlusion in neuropathic patients is consistent with an endothelial cell defect. These findings are in marked contrast to those in 20 uncomplicated Type 2 diabetic patients who had diminished basal and post-venous occlusion fibrinolytic activity with high basal t-PA (13.4 (9.8-16.8) mu-g l-1) and PAI-1 (26.5 (12.4-39.6) mu-g l-1) antigen. The differing fibrinolytic responses may contribute to the heterogeneous nature of vascular disease in diabetes.

引用

页码：954 / 959

页数：6

共 40 条

[1]

Collen D., On the regulation and control of fibrinolysis, Thromb Haemostas, 43, pp. 77-89, (1980)

[2]

Bachmann F., Kruithof EKO, Tissue plasminogen activator: chemical and physiological aspects, Semin Thromb Haemostas, 10, pp. 6-17, (1984)

[3]

Kruithof EKO, Tran-Tang C., Bachman F., The fast acting inhibitor of tissue‐type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase, Thromb Haemostas, 55, pp. 65-69, (1986)

[4]

Kruithof EKO, Gudinchet A., Bachmann F., Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states, Thromb Haemostas, 59, pp. 7-12, (1988)

[5]

Grant PJ, Medcalf RL, Hormonal regulation of haemostasis and the molecular biology of the fibrinolytic system, Clin Sci, 78, pp. 3-11, (1990)

[6]

Nilsson IM, Ljungner H., Tengborn L., Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentrations of plasminogen activator or increased concentration of plasminogen activator inhibitor, Br Med J, 290, pp. 1453-1456, (1985)

[7]

Juhan-Vague I., Valadier J., Alessi MC, Aillaud MF, Ansaldi J., Philip-Joet C., Et al., Deficient t‐PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep vein thrombosis, Thromb Haemostas, 57, pp. 67-72, (1987)

[8]

Sue-Ling HM, Johnston D., McMahon MJ, Philips PR, Davies JA, Preoperative identification of patients at high risk of deep vein thrombosis after elective abdominal surgery, Lancet, 1, pp. 1173-1176, (1986)

[9]

Hamsten A., Wiman B., DeFaire U., Blomback M., Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction, New Engl J Med, 313, pp. 1557-1563, (1985)

[10]

Meade TW, Chakrabarti R., Haines AP, North WRS, Stirling Y., Thompson SG, Et al., Haemostatic function and cardiovascular death: early results of a prospective study, Lancet, 1, pp. 1050-1053, (1980)

← 1 2 3 4 →